Product

Trimethoprim Sulfamethoxazole

2 clinical trials

3 indications

Indication
Cystic Fibrosis
Clinical trial
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Status: Recruiting, Estimated PCD: 2025-08-30
Clinical trial
Trimethoprim-Sulfamethoxazole Effects on the Nasal Microbiome in Granulomatosis With Polyangiitis
Status: Active (not recruiting), Estimated PCD: 2025-09-30